the feasibility of assessing regional cerebral perfusion using the new brain imaging agent n , n , n'-trimethyl-n'- ( 2 ) -hydroxy-3-methyl-5- ( 123i ) iodobenzyl ) -1,3-propanediamine 2 hcl ( i-123 hipdm ) and single photon emission computed tomography ( spect ) was evaluated in normal subjects and patients with cerebrovascular disorders .
C0006104
brain
C0007820
cerebrovascular disorders